Patent · US Active

Composition and methods for treating intestinal hyperpermeability

US9757348B2 · kind B2 · utility

6Cited by
14References
14Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 26, 2016
Grant dateSep 12, 2017
Priority date—
Expiry dateApr 26, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods, compositions, and kits for treating intestinal hyperpermeability in a subject in need thereof, including conditions such as hyperglycemia and underlying diseases such as diabetes, autism, fibromyalgia, inflammatory bowel disease (IBD), graft versus host disease (GVHD), HIV/AIDS, multiple organ dysfunction syndrome, irritable bowel syndrome (IBS), celiac disease, eczema, psoriasis, acute pancreatitis, Parkinson's disease, depression, chronic fatigue syndrome, asthma, multiple sclerosis, arthritis, ankylosing spondylitis, nonalcoholic fatty liver disease, alcoholic cirrhosis, environmental enteropathy, or kwashiorkor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.